About: DTP-HepB vaccine

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B. A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014.

Property Value
dbo:abstract
  • DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B. A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014. A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between DTP-HepB vaccine and Hib vaccine administered separately and pentavalent DTP-HepB-Hib vaccine. (en)
dbo:alternativeName
  • Tritanrix-HepB (en)
dbo:casNumber
  • 1012056-47-1
dbo:wikiPageID
  • 57901919 (xsd:integer)
dbo:wikiPageLength
  • 3590 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1123657193 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • J07 (en)
dbp:atcSuffix
  • CA05 (en)
dbp:casNumber
  • 1012056 (xsd:integer)
dbp:class
dbp:component
  • DTP vaccine (en)
  • Hepatitis B vaccine (en)
dbp:drugName
  • DTP-HepB (en)
dbp:routesOfAdministration
  • Intramuscular injection (en)
dbp:tradename
  • Tritanrix-HepB (en)
dbp:type
  • combo (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B. A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014. (en)
rdfs:label
  • DTP-HepB vaccine (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • DTP-HepB (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License